🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Dapagliflozin 10 mg + Metformin 1000 mg XR

Found 13 matching trials

Dapagliflozin and Metformin,Alone and in Combination, in Overweight/Obese Prior GDM Women

PHASE3

Women with a history of gestational diabetes (GDM) are at substantially inc...

Status

Completed

Location

Woman's Hospital

Start Date

2015-09-22

Trial ID

NCT02338193

Treatments Being Tested

DAPA/MET XR DAPA MET XR

Bioavailability Study of Fixed Dose Combination (FDC) Formulations of Dapagliflozin and Metformin XR Versus Individual Component Coadministered to Healthy Subjects in a Fasted State

PHASE1

To assess the relative bioavailability of dapagliflozin and metformin from ...

Status

Completed

Location

Ppd Development, Lp

Start Date

2009-11

Trial ID

NCT01002807

Treatments Being Tested

Dapagliflozin Metformin XR Glucophage

A Study to Assess the Bioequivalence of Fixed Dose Combination of Dapagliflozin/Metformin XR Relative to Co-administration of the Individual Components in Healthy Chinese Subjects.

PHASE1

To assess the bioequivalence between dapagliflozin/metformin XR FDC tablet ...

Status

Completed

Location

Research Site

Start Date

2021-04-12

Trial ID

NCT04856007

Treatments Being Tested

Dapagliflozin/metformin XR FDC 5/500 mg Dapagliflozin/metformin XR FDC 10/1000 mg Dapagliflozin 5 mg + Metformin 500 mg XR Dapagliflozin 10 mg + Metformin 1000 mg XR

A Clinical Study in Healthy Adults to See How the Body Processes and How Safe a Tablet That Combines Gemigliptin, Dapagliflozin, and Metformin is, Compared With Taking Zemiglo and Xigduo XR Together While Fasting.

PHASE1

Bioequivalence study for the fixed-dose combination of Gemigliptin/Dapaglif...

Status

Completed

Location

Jeonbuk National University Hospital

Start Date

2026-01-09

Trial ID

NCT07399470

Treatments Being Tested

Test drug: Fixed-dose combination of gemigliptin/dapagliflozin/metformin 50/10/1000 mg Reference drug: Gemigliptin (Zemiglo) 50mg, Dapagliflozin/metformin (Xigduo XR) 10/1000 mg

An Open-label, Randomized, Crossover Study of Comparative Pharmacokinetics and Bioequivalence of Dapagliflozin + Metformin, 10 mg + 1000 mg Versus the Combined Use of Forxiga™, 10 mg and Two Glucophage® Long, ER Tablets, 500 mg Co-administered to Healthy Volunteers Under Standard Fed Conditions

PHASE1

The aim of this study is to demonstrate bioequivalence of fixed dose combin...

Status

Completed

Location

Research Site

Start Date

2016-03-30

Trial ID

NCT02722239

Treatments Being Tested

Xigduo XR Metformin ER (Glucophage® long)Dapagliflozin (Forxiga)

A Clinical Study to See How the Body Handles and How Safe a Combination Tablet of Gemigliptin, Dapagliflozin, and Metformin 50/10/1000mg is Compared to Taking Gemigliptin 50mg Separately With Dapagliflozin/Metformin 10/1000mg in Healthy Adults After a Meal

PHASE1

Bioequivalence study for the fixed-dose combination of gemigliptin/dapaglif...

Status

Completed

Location

Seoul National University Hospital

Start Date

2025-09-29

Trial ID

NCT07333742

Treatments Being Tested

Test drug: Fixed-dose combination (FDC) of gemigliptin/dapagliflozin/metformin 50/10/1000 mg Reference drug: gemigliptin (Zemiglo) 50mg, Xigduo XR 10/1000 mg

A Study to Assess the Bioequivalence of Dapagliflozin/Metformin XR Fixed-dose Combination Tablets in Healthy Subjects

PHASE1

This is a bioequivalence study to compare 2 fixed-dose combination tablets ...

Status

Completed

Location

Research Site

Start Date

2015-12-21

Trial ID

NCT02637037

Treatments Being Tested

dapagliflozin/metformin XR 5/500 mg test drug (Mount Vernon)dapagliflozin/metformin XR 5/500 mg reference drug (Humacao)dapagliflozin/metformin XR 10/1000 mg test drug (Mount Vernon)dapagliflozin/metformin XR 10/1000 mg reference drug (Humacao)

The Purpose of the Study is to Compare Two Fixed Dose Combination Tablets of Dapagliflozin/Metformin XR in Healthy Subjects Under Fasting and Fed Conditions

PHASE1

This is a bioequivalence study of two doses of the dapagliflozin/metformin ...

Status

Completed

Location

Research Site

Start Date

2017-09-26

Trial ID

NCT03216278

Treatments Being Tested

Dapagliflozin/metformin XR 5/500mg Dapagliflozin/metformin XR 5/500 mg Dapagliflozin/metformin XR 5/500mg Dapagliflozin/metformin XR 5/500mg Dapagliflozin/metformin XR 10/1000mg Dapagliflozin/metformin XR 10/1000mg Dapagliflozin/metformin XR 10/1000mg Dapagliflozin/metformin XR 10/1000mg

Effect of Dapagliflozin/Metformin XR vs Monotherapies on Anthropometric Indicators in Obesity

PHASE4

Obesity has increased to alarming levels in the world. Currently it is esti...

Status

Unknown

Location

Instituto de Terapeútica Experimental y Clínica. Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara

Start Date

2019-07-30

Trial ID

NCT03710460

Treatments Being Tested

Dapagliflozin Dapagliflozin plus Metformin XR Metformin XR

Effect of Farxiga on Renal Function and Size in Type 2 Diabetic Patients With Hyperfiltration

PHASE4

The investigators propose to treat newly diagnosed, hyperfiltering T2DM pat...

Status

Completed

Location

University Health Systems Texas Diabetic Institute

Start Date

2016-12-20

Trial ID

NCT02911792

Treatments Being Tested

Dapagliflozin Metformin Glipizide 5 MG

Previous Next